A.S. Mangione
Nonparalytic botulinum molecules for the control of pain
Mangione, A.S.; Obara, I.; Maiarú, M.; Geranton, S.M.; Tassorelli, C.; Ferrari, E.; Leese, Ch; Davletov, B.; Hunt, S.P.
Authors
I. Obara
M. Maiarú
S.M. Geranton
C. Tassorelli
E. Ferrari
Ch Leese
B. Davletov
S.P. Hunt
Abstract
Local injections of botulinum toxins have been reported to be useful not only for the treatment of peripheral neuropathic pain and migraine but also to cause long-lasting muscle paralysis, a potentially serious side effect. Recently, a botulinum A-based molecule (“BiTox”) has been synthesized that retains neuronal silencing capacity without triggering muscle paralysis. In this study, we examined whether BiTox delivered peripherally was able to reduce or prevent the increased nociceptive sensitivity found in animal models of inflammatory, surgical, and neuropathic pain. Plasma extravasation and edema were also measured as well as keratinocyte proliferation. No motor deficits were seen and acute thermal and mechanical nociceptive thresholds were unimpaired by BiTox injections. We found reduced plasma extravasation and inflammatory edema as well as lower levels of keratinocyte proliferation in cutaneous tissue after local BiTox injection. However, we found no evidence that BiTox was transported to the dorsal root ganglia or dorsal horn and no deficits in formalin-elicited behaviors or capsaicin or formalin-induced c-Fos expression within the dorsal horn. In contrast, Bitox treatment strongly reduced A-nociceptor-mediated secondary mechanical hyperalgesia associated with either complete Freund’s adjuvant (CFA)-induced joint inflammation or capsaicin injection and the hypersensitivity associated with spared nerve injury. These results imply that although local release of neuromodulators from C-fibers was inhibited by BiTox injection, C-nociceptive signaling function was not impaired. Taken together with recent clinical data the results suggest that BiTox should be considered for treatment of pain conditions in which A-nociceptors are thought to play a significant role.
Citation
Mangione, A., Obara, I., Maiarú, M., Geranton, S., Tassorelli, C., Ferrari, E., …Hunt, S. (2016). Nonparalytic botulinum molecules for the control of pain. PAIN, 157(5), 1045-1055. https://doi.org/10.1097/j.pain.0000000000000478
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 22, 2015 |
Online Publication Date | May 1, 2016 |
Publication Date | May 1, 2016 |
Deposit Date | May 4, 2016 |
Publicly Available Date | May 4, 2016 |
Journal | PAIN |
Print ISSN | 0304-3959 |
Electronic ISSN | 1872-6623 |
Publisher | Lippincott, Williams & Wilkins |
Peer Reviewed | Peer Reviewed |
Volume | 157 |
Issue | 5 |
Pages | 1045-1055 |
DOI | https://doi.org/10.1097/j.pain.0000000000000478 |
Public URL | https://durham-repository.worktribe.com/output/1405646 |
Files
Published Journal Article
(812 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
© 2016 International Association for the Study of Pain. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
You might also like
Homers at the Interface between Reward and Pain
(2013)
Journal Article
Synthetic self-assembling clostridial chimera for modulation of sensory functions
(2013)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search